Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples